Back to Search
Start Over
Ibrutinib/rituximab: Lack of efficacy.
- Source :
-
Reactions Weekly . 5/25/2024, Vol. 2009 Issue 1, p294-294. 1p. - Publication Year :
- 2024
-
Abstract
- A man with refractory stage IVB mantle cell lymphoma exhibited lack of efficacy during treatment with rituximab and ibrutinib. Despite previous treatments and autologous stem cell transplant, his lymphoma continued to progress. He underwent CAR-T-cell therapies, which resulted in complications including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. Post-treatment, he developed sclerosing cholangitis and his condition worsened, leading to a transition to comfort care. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 01149954
- Volume :
- 2009
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Reactions Weekly
- Publication Type :
- Periodical
- Accession number :
- 177510927
- Full Text :
- https://doi.org/10.1007/s40278-024-59550-x